Deprescribing antihypertensive medication was not associated with the risk of hospitalization for MI or stroke compared to continuation (HR 0.93; 95% CI 0.70-1.26).
Observational (n=13,096)
Yes
Does deprescribing antihypertensive medication reduce hospitalization for MI or stroke in long-term care residents?
Deprescribing antihypertensive medications in older long-term care residents does not appear to increase the risk of hospitalization for MI or stroke.
Hazard Ratio: 0.93 (95% CI 0.7–1.26)
Absolute Event Rate: 11.2% vs 8.8%
Importance: The practice of deprescribing antihypertensive medications is common among long-term care residents, yet the effect on cardiovascular outcomes is unclear. Objective: To compare the incidence of hospitalization for myocardial infarction (MI) or stroke among long-term care residents who are deprescribed or continue antihypertensive therapy. Design, Setting, and Participants: This comparative effectiveness research study used target trial emulation with observational electronic health record data from long-term care residents aged 65 years or older admitted to US Department of Veterans Affairs community living centers between October 1, 2006, and September 30, 2019, and taking at least 1 antihypertensive medication. Analyses were conducted between August 2023 and August 2024. Exposure: A reduction in the number of antihypertensive medications or dose (by ≥30%), assessed using barcode medication administration data. Main Outcome and Measures: Incidence of MI and stroke hospitalization up to 2 years was assessed using International Classification of Diseases, Ninth Revision and International Statistical Classification of Diseases and Related Health Problems, Tenth Revision codes. A pooled logistic regression model with inverse probability of treatment weighting (IPTW) and inverse probability of censoring weighting (IPCW) was used to estimate per-protocol effects. Results: Of 13 096 long-term care residents (97.4% men; median age, 77 years IQR, 70-84 years) taking antihypertensive medication, 17.8% were deprescribed antihypertensive medication over a period of 12 weeks. The estimated unadjusted cumulative incidence of stroke or MI hospitalization over 2 years was similar among residents who were and were not deprescribed antihypertensives in per-protocol analyses (11.2% vs 8.8%; difference, 2.4 percentage points 95% CI, -2.3 to 7.1 percentage points). Participant characteristics were balanced after applying IPTW and IPCW; all standardized mean differences were less than 0.05. After full adjustment for confounding and informative censoring, the per-protocol analysis results showed no association of antihypertensive deprescribing with MI or stroke hospitalization (hazard ratio, 0.93; 95% CI, 0.70-1.26). Conclusions and Relevance: In this comparative effectiveness research study, deprescribing antihypertensive medication was not associated with risk of hospitalization for MI or stroke in long-term care residents. These findings may be informative for long-term care residents and clinicians who are considering deprescribing antihypertensive medications.
Odden et al. (Mon,) conducted a observational in Long-term care residents taking antihypertensive medication (n=13,096). Deprescribing antihypertensive medication vs. Continuing antihypertensive therapy was evaluated on Incidence of MI and stroke hospitalization up to 2 years (HR 0.93, 95% CI 0.70-1.26). Deprescribing antihypertensive medication was not associated with the risk of hospitalization for MI or stroke compared to continuation (HR 0.93; 95% CI 0.70-1.26).